Chair: Richard Frackowiak, Head of the Department of Clinical Neurosciences at the Université de Lausanne, Switzerland
Professor Frackowiak’s interest is in human brain structure and function relationships in health and disease. Formerly Foundation Professor of Cognitive Neurology at University College London (UCL), Director of the Department of Cognitive Studies at the Ecole Normale Supérieure Paris, Wellcome Trust Principal Clinical Research Fellow, Dean-Director of the Institute of Neurology and Vice-Provost of UCL, he founded the Wellcome Department of Imaging Neuroscience (FIL) in 1994. MA and MD Cambridge, DSc London University, he holds an honorary doctorate from Liege University and professorship from UCL. He is a Fellow of the Academies of Medical Sciences of the UK, France Belgium and the Academia Europaea and a foreign associate of the Institute of Medicine USA.
Henrique Barros, Director of the Department of Clinical Epidemiology, Predictive Medicine and Public Health at the Medical School of University of Portugal, Portugal
Henrique Barros has been Professor in the Medical School of the University of Porto in Portugal since 1999. His research activities in national and international projects have been mainly in clinical and perinatal epidemiology, cardiovascular and infectious diseases and cancer. He is associate editor of the European Journal of Epidemiology and member of the editorial board of BMC Public Health, Cadernos de Saúde Pública and Journal of Epidemiology and Community Health.
Håkan Billig, Professor in Physiology and Head of the Endocrinology Research group at the Sahlgrenska Academy of Gothenburg University in Sweden
Professor’s Billig research interest has been on ovarian metabolism, regulation of follicular development and gonadal apoptosis with special emphasis on progesterone and oestrogen receptor subtype regulation and function in reproductive tissues. Currently, the main focus of his research is on translational projects studying Fallopian tube physiology and tubal ectopic pregnancy using the advantages of combining clinical and preclinical studies. Håkan Billig is Chair of the Research Policy Board at the Swedish Society of Medicine, and currently Member of the European Strategy Forum on Research Infrastructures (Health and Food) and Chair of the Biobanking and Molecular Resources Infrastructure (BBMRI) in Sweden.
Kari Bø, Rector of the Norwegian School of Sport Sciences in Oslo, Norway
Professor Bø is a physical therapist and an exercise scientist at the Norwegian School of Sport Sciences, in the department of Sports Medicine. She is also a project leader at Akershus University Hospital, Department of Obstetrics and Gynecology, and is board member of “The pelvic floor Center” at the same hospital. Her main research interest is pelvic floor function and dysfunction, exercise science and women’s health.
Monique Capron, Professor of Immunology at Lille University (France) and Head of Department at the Pasteur Institute of Lille, France
Professor Capron’s research focuses on the mechanisms of immunity against a major parasitic infection: schistosomiasis. Her main contribution was to establish parallelism in the effector mechanisms in parasitic infections and allergic diseases. These results not only have fundamental implications but have also allowed a better definition of vaccine strategy, leading to the first vaccine clinical trials in schistosomiasis immunity. Professor Capron is President of the Board of Administrators of the French Research Preforming Organisation INSERM since 2003.
Adam Cohen, Director of the Centre for Human Drug Research (CHDR), The Netherlands
Professor Cohen is Director of the CHDR, a research centre for early drug development and proof of concept studies in healthy subjects and patients. His research interests are in cardiovascular and CNS early drug development with special attention to advanced methodology development. He is professor of Clinical Pharmacology at Leiden University and has a clinical attachment at the department of nephrology at Leiden University Medical Centre. He was vice-chairman of the Central Ethics Committee and the Competent Authority (CCMO) of the Netherlands and is European editor of the British Journal of Clinical Pharmacology.
Annette Grüters-Kieslich, Dean of the Charité-Universitätsmedizin Berlin, Germany
Annette Grüters-Kieslich completed her studies at the Medical School of the Free University Berlin in 1980 and received her doctoral degree in 1982. In 1998 she became Professor for Paediatric Endocrinology. In 2004 she was appointed as full professor in Pediatrics. Since 2005 she has been the Medical Director of the Charité Center for Women and Child Health and Human Genetics. In 2008 she was elected as Dean of the Charité-Universitätsmedizin Berlin.
Stephen Holgate, Clinical Professor of Immunopharmacology at the School of Medicine, Southampton, United Kingdom
Professor Holgate’s research focuses on the mechanisms of asthma. He has utilised many approaches to study this disease, including epidemiology, genetics, pathology, microbiology and immunology, pharmacology and experimental medicine. His research has informed guidelines on asthma management and has identified and validated novel therapeutic targets. Professor Holgate is a Past President of the British Society of Allergy and Clinical Immunology and the British Thoracic Society. He is currently Member of MRC Strategy Board and Chair of Panel A (covering Medicine, Health and Life Sciences) of the UK Research Excellence Framework 2014, to assess research and impact in all UK Universities over the previous five years.
Andres Metspalu, Professor of biotechnology and Director of the Estonian Genome Center at the University of Tartu
His main scientific interests are human genomics, genetics of complex diseases and population-based bio banks and their applications in translational research. He has published more than 300 papers and chapters in international peer review journals and books. From 1996 to 2008 he was the founder and head of the Molecular Diagnostic Center of the Tartu University Hospital. He was a former president of the European Society of the Human Genetics. He is one of the founders and directors of the P3G Consortium of Biobanks and BBMRI-ERIC. Since 2007 he has been a member of the ScanBalt academy. In 2010 he was elected to the Estonian Academy of Sciences.
Kirsi Pietiläinen, Associate Professor at the Faculty of Medicine, University of Helsinki
Professor Pietiläinen runs a research group at the Obesity Research Unit, University of Helsinki. Her research interest in translational research is mainly focused on obesity-related diseases, adipose tissue and muscle metabolism and mitochondrial function. Professor Pietiläinen has been the Principal or Co-investigator in 8 multi-center clinical trials on obesity or type 2 diabetes. She is the Chief Physician at the Obesity Center for the Management of Morbid obesity at the Abdominal Center, Endocrinology, Helsinki University Central Hospital, and is the chair of the Finnish Obesity Treatment Guidelines and member of the expert group of the Finnish Diabetes Treatment Guidelines.
Tullio Pozzan, Professor of General Pathology at the University of Padova, Italy
Tullio Pozzan is Professor of General Pathology at the University of Padova, Italy. His research is focused on different aspects of cell signaling, in particular the mechanism of second messenger homeostasis. Professor Pozzan has contributed to the development of different methodologies to investigate ion concentration or other messengers in living cells with fluorescent or chemo-luminescent probes and applied them to investigate the subcellular heterogeneity of signaling molecules in living cells. He has extensively studied the role of organelles in cell physiopathology, in different cellular and tissue models. He is currently Director of the Department of Biomedical Sciences at the Consiglio Nazionale delle Richerche (CNR).
Martin Vingron, Director at the Max Planck Institute for Molecular Genetics, Head of Computational Molecular Biology Department, Berlin, Germany
As a computational biologist, Professor Vingron has contributed to the development of mathematical and statistical methods for analysing biological data. His present research focus is in regulatory genomics, studying gene regulation through computational analysis of sequences and functional genomics data. Since 2000 he has headed the Department of Computational Molecular Biology at the MPI for Molecular Genetics in Berlin and he is also an Adjunct Professor of Computer Science at Freie Universität Berlin.